Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Welcome Evotec

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 17, 2022 3:01am

164 Views

Post# 34688296

RE:RE:Welcome Evotec

I'll have to wait until the SVA news release is out to really know what to think. Like MS I need to know what the terms of the 20mil euro $ is. As I suspected, the price being held at 1.40 meant dilution coming. How much I don't know. It better be at a premium to 1.40. Partnership selection I am happy with. Evotec did buy sanofis cells some years ago and they are supposedly some of the best out there, much better than semmas. German markets aren't reacting too terribly, trading up 17 percent at the time of the post.